1N-alkyl-n-arylpyrimidinamines and derivatives thereof
US6342503B1 · kind B1 · utility
89Cited by
18References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 1998 |
| Grant date | Jan 29, 2002 |
| Priority date | — |
| Expiry date | Jan 7, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer'disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R1, R3, R4, R5, Z, Y, V, X, X′, J, K, L, and M are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.